Publications by authors named "Devayani Machiraju"

Claim this Profile
T
The immune checkpoint LAG-3 is expressed by melanoma cells and correlates with clinical progression of the melanoma.
Melanie Wiecken, Devayani Machiraju, Shounak Chakraborty, Eva-Maria Mayr, Bénédicte Lenoir

Oncoimmunology· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Artificial intelligence-assisted assessment of metabolic response to tebentafusp in metastatic uveal melanoma: a long axial field-of-view [F]FDG PET/CT study.
Christos Sachpekidis, Devayani Machiraju, Dimitrios Stefanos Strauss, Leyun Pan, Annette Kopp-Schneider

Eur J Nucl Med Mol Imaging· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monitoring soluble cMET and ctDNA in metastatic uveal melanoma patients to track early disease progression on immunotherapies.
Devayani Machiraju, Christian H Ziener, Elena Clementi, Francisco García-Asencio, Jennifer Hüllein

J Exp Clin Cancer Res· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tebentafusp Induces a T-Cell-Driven Rash in Melanocyte-Bearing Skin as an Adverse Event Consistent with the Mechanism of Action.
Jessica C Hassel, Sarah Stanhope, Alexander Greenshields-Watson, Devayani Machiraju, Alexander Enk

J Invest Dermatol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CMV IgG in the blood is not associated with hepatitis but correlates with poor outcomes in immunotherapy treated melanoma patients.
Sophia B Strobel, Devayani Machiraju, Melanie Wiecken, Jasmin Richter, Julian A F Klein

Cancer Immunol Immunother· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early Serum Markers for Immune Checkpoint Inhibitor Induced Hypophysitis in Melanoma Patients.
Fouad Mitri, Devayani Machiraju, Christina Naoum, Jessica C Hassel

Cancers (Basel)· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid disease progression on immune checkpoint inhibitors in young patients with stage IV melanoma.
Devayani Machiraju, Sarah Schäfer, Philip Beckhove, Jasmin Roth, Carsten Schulz

Front Med (Lausanne)· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting the cMET pathway to enhance immunotherapeutic approaches for mUM patients.
Devayani Machiraju, Jessica C Hassel

Front Oncol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune-related adverse events of COVID-19 vaccination in skin cancer patients receiving immune-checkpoint inhibitor treatment.
Sophia B Strobel, Devayani Machiraju, Katharina A Kälber, Jessica C Hassel

Cancer Immunol Immunother· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of radio-immunotherapy sequence on immunological responses and clinical outcomes in patients with melanoma brain metastases (ELEKTRA).
Jessica C Hassel, Timo E Schank, Heiko Smetak, Jasmin Mühlbauer, Martin Salzmann, Devayani Machiraju

Oncoimmunology· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TCR-Directed Therapy in the Treatment of Metastatic Uveal Melanoma.
Sophia B Strobel, Devayani Machiraju, Jessica C Hassel

Cancers (Basel)· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potential Reasons for Unresponsiveness to Anti-PD1 Immunotherapy in Young Patients with Advanced Melanoma.
Devayani Machiraju, Sarah Schäfer, Jessica C Hassel

Life (Basel)· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Soluble immune checkpoints and T-cell subsets in blood as biomarkers for resistance to immunotherapy in melanoma patients.
Devayani Machiraju, Melanie Wiecken, Nina Lang, Ingrid Hülsmeyer, Jasmin Roth

Oncoimmunology· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of Potential Targets for Cell-Based Therapies on Melanoma Cells.
Sophia B Strobel, Devayani Machiraju, Ingrid Hülsmeyer, Jürgen C Becker, Annette Paschen

Life (Basel)· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liquid Biopsy: Value for Melanoma Therapy.
Kristina Buder-Bakhaya, Devayani Machiraju, Jessica C Hassel

Oncol Res Treat· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
STAT5 expression correlates with recurrence and survival in melanoma patients treated with interferon-α.
Devayani Machiraju, Iris Moll, Christoffer Gebhardt, Antje Sucker, Kristina Buder-Bakhaya

Melanoma Res· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Computationally-Guided Development of a Stromal Inflammation Histologic Biomarker in Lung Squamous Cell Carcinoma.
Daniel Xia, Ruben Casanova, Devayani Machiraju, Trevor D McKee, Walter Weder

Sci Rep· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis